We are live on ! Find out more
RXRAW

RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW

Delisted

RXRAW was delisted on the 20th of December, 2022.

0 hedge funds and large institutions have $0 invested in RXR Acquisition Corp. Warrants to purchase Class A common stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 50 → 0 (-50)

100% less capital invested

Capital invested by funds: $1.61M → $0 (-$1.61M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 50

Holders
–
Holders Change
-50
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
50
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

RXRAW Hedge Fund Activity: Q4 2022 in Review

0 of the 6,240 institutional investors tracked by Wall St. Rank reported a position in RXR Acquisition Corp. Warrants to purchase Class A common stock (RXRAW) for Q4 2022, worth a combined $0 — down 100% from $1.61M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of RXRAW and 0 opened new positions — a net loss of 50 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $890K sold.

  • 0 institutional investors held RXR Acquisition Corp. Warrants to purchase Class A common stock (RXRAW) as of Q4 2022, down from 50 in Q3 2022.
  • Funds reported $0 of RXR Acquisition Corp. Warrants to purchase Class A common stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new RXR Acquisition Corp. Warrants to purchase Class A common stock positions in Q4 2022 and 50 closed out, a net change of -50 holders.
  • The largest RXR Acquisition Corp. Warrants to purchase Class A common stock seller in Q4 2022 was Radcliffe Capital Management, an estimated $890K sold.

Based on aggregated 13F filings for Q4 2022.